Pharma Marketing News Vol. 11, No. 7: 26 July 2012
Welcome to Volume 11, Issue #7 (26 JULY 2012) of Pharma Marketing News.
Days of Live Pharma Reps are Numbered: M&A’s and Outsourcing – the “Bain/Bane” of...
Last night, my sons and I attended a NJ BioPharma Networking Group (NJBPNG) meetup at the Princeton Sports Bar and Grille. NJBPNG is an...
iPad Effectiveness in Clinical Settings: Understanding What Physicians and Patients Desire from mHealth Applications
A conversation with Douglas Elwood, MD, MBA, Director, GMI Strategy and Innovation at Bristol-Myers Squibb, about one of the country's first and largest studies examining the utility of using iPads and other mobile devices in a real-time clinical setting, gathering insights on multiple variables associated with overall usage, app/website preferences, and aspects of daily clinical decision making and interactions.
Meet “Ceyockey,” an Astrazeneca Pharma Wikipedian
The most visible and most accessed example of crowd-sourced “creative commons” information is Wikipedia where “wikipedians” – i.e., people who write and edit the...
Congress Gives FDA 2 Years to Issue Social Media Guidance. All Bark, No Bite.
A little-noticed "Miscellaneous Provision" of the "Food and Drug Administration
Safety and Innovation Act" (aka PDUFA, pdf), which was signed into law by president Obama...
OMG, LCOI! Open Source Pharma: Creative Commons Coming To Pharma
I had an interesting phone conversation yesterday with Jerry Matczak, Community Manager, Lilly Clinical Open Innovation, Eli Lilly and Company. Yes, "Open" and "Innovation"...
“The Crowd is My Only Drug,” Says GSK Olympics Anti-Doping DTC Ad Campaign
GlaxoSmithKline (GSK) will raise awareness of its role in anti-doping measures at the London 2012 Olympic Games as part of its first consumer-facing corporate...
JNJ Attempts YouTube Humor to Promote a DTC Advertising Goal
The goal of every direct-to-consumer (DTC) ad is to get people to visit their doctors and ask about the advertised Rx drug. But are...
EU’s EMA Plans to Open Up Proprietary Drug Trial Data to Outside Investigators
European Medicines Agency (EMA) -- the European drug regulator -- "is opening its data vaults to systematic scrutiny in a move that will let...
“We do things at Pfizer that are best for shareholders of Pfizer.” You Gotta...
I can't believe a Pfizer "spokesperson" (Corporate Secretary and Chief Governance Counsel, Matthew Lepore) said:
“We do things at Pfizer that are best for shareholders...
